H2N2V1, PubMed, Checkpoint, bibRecord, 000033

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).

Identifieur interne : 000033 ( PubMed/Checkpoint ); précédent : 000032; suivant : 000034

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).

Auteurs : Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]

Source :

PloS one [ 1932-6203 ] ; 2017.

RBID : pubmed:28715468

Descripteurs français

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Animals, Antibodies, Viral (immunology), Birds, Child, Child, Preschool, Cross Reactions, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H5N1 Subtype (immunology), Influenza A Virus, H5N1 Subtype (isolation & purification), Influenza A Virus, H7N7 Subtype (immunology), Influenza A Virus, H7N7 Subtype (isolation & purification), Influenza A Virus, H9N2 Subtype (immunology), Influenza A Virus, H9N2 Subtype (isolation & purification), Influenza in Birds (pathology), Influenza in Birds (virology), Influenza, Human (pathology), Influenza, Human (virology), Middle Aged, Young Adult.
MESH :
- chemical , immunology : Antibodies, Viral.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H5N1 Subtype, Influenza A Virus, H7N7 Subtype, Influenza A Virus, H9N2 Subtype.
- isolation & purification : Influenza A Virus, H5N1 Subtype, Influenza A Virus, H7N7 Subtype, Influenza A Virus, H9N2 Subtype.
- pathology : Influenza in Birds, Influenza, Human.
- virology : Influenza in Birds, Influenza, Human.
- Adolescent, Adult, Aged, Animals, Birds, Child, Child, Preschool, Cross Reactions, Humans, Middle Aged, Young Adult.

Abstract

Epidemics of influenza A vary greatly in size and age distribution of cases, and this variation is attributed to varying levels of pre-existing immunity. Recent studies have shown that antibody-mediated immune responses are more cross-reactive than previously believed, and shape patterns of humoral immunity to influenza A viruses over long periods. Here we quantify antibody responses to the hemagglutinin subunit 1 (HA1) across a range of subtypes using protein microarray analysis of cross-sectional serological surveys carried out in the Netherlands before and after the A/2009 (H1N1) pandemic. We find significant associations of responses, both within and between subtypes. Interestingly, substantial overall reactivity is observed to HA1 of avian H7N7 and H9N2 viruses. Seroprevalence of H7N7 correlates with antibody titers to A/1968 (H3N2), and is highest in persons born between 1954 and 1969. Seroprevalence of H9N2 is high across all ages, and correlates strongly with A/1957 (H2N2). This correlation is most pronounced in A/2009 (H1N1) infected persons born after 1968 who have never encountered A/1957 (H2N2)-like viruses. We conclude that heterosubtypic antibody cross-reactivity, both between human subtypes and between human and nonhuman subtypes, is common in the human population.

DOI: 10.1371/journal.pone.0181093
PubMed: 28715468

Affiliations:

Pays-Bas

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000033
to stream PubMed, to step Curation: 000033

Links to Exploration step

pubmed:28715468

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).</title>
<author><name sortKey="Te Beest, Dennis E" sort="Te Beest, Dennis E" uniqKey="Te Beest D" first="Dennis E" last="Te Beest">Dennis E. Te Beest</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Bruin, Erwin" sort="De Bruin, Erwin" uniqKey="De Bruin E" first="Erwin" last="De Bruin">Erwin De Bruin</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Imholz, Sandra" sort="Imholz, Sandra" uniqKey="Imholz S" first="Sandra" last="Imholz">Sandra Imholz</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Koopmans, Marion" sort="Koopmans, Marion" uniqKey="Koopmans M" first="Marion" last="Koopmans">Marion Koopmans</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Boven, Michiel" sort="Van Boven, Michiel" uniqKey="Van Boven M" first="Michiel" last="Van Boven">Michiel Van Boven</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28715468</idno>
<idno type="pmid">28715468</idno>
<idno type="doi">10.1371/journal.pone.0181093</idno>
<idno type="wicri:Area/PubMed/Corpus">000033</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000033</idno>
<idno type="wicri:Area/PubMed/Curation">000033</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000033</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000033</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000033</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).</title>
<author><name sortKey="Te Beest, Dennis E" sort="Te Beest, Dennis E" uniqKey="Te Beest D" first="Dennis E" last="Te Beest">Dennis E. Te Beest</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Bruin, Erwin" sort="De Bruin, Erwin" uniqKey="De Bruin E" first="Erwin" last="De Bruin">Erwin De Bruin</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Imholz, Sandra" sort="Imholz, Sandra" uniqKey="Imholz S" first="Sandra" last="Imholz">Sandra Imholz</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Koopmans, Marion" sort="Koopmans, Marion" uniqKey="Koopmans M" first="Marion" last="Koopmans">Marion Koopmans</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Boven, Michiel" sort="Van Boven, Michiel" uniqKey="Van Boven M" first="Michiel" last="Van Boven">Michiel Van Boven</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Birds</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross Reactions</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H5N1 Subtype (immunology)</term>
<term>Influenza A Virus, H5N1 Subtype (isolation & purification)</term>
<term>Influenza A Virus, H7N7 Subtype (immunology)</term>
<term>Influenza A Virus, H7N7 Subtype (isolation & purification)</term>
<term>Influenza A Virus, H9N2 Subtype (immunology)</term>
<term>Influenza A Virus, H9N2 Subtype (isolation & purification)</term>
<term>Influenza in Birds (pathology)</term>
<term>Influenza in Birds (virology)</term>
<term>Influenza, Human (pathology)</term>
<term>Influenza, Human (virology)</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe chez les oiseaux (anatomopathologie)</term>
<term>Grippe chez les oiseaux (virologie)</term>
<term>Grippe humaine (anatomopathologie)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Oiseaux</term>
<term>Réactions croisées</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H5N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H5N1 du virus de la grippe A (isolement et purification)</term>
<term>Sous-type H7N7 du virus de la grippe A (immunologie)</term>
<term>Sous-type H7N7 du virus de la grippe A (isolement et purification)</term>
<term>Sous-type H9N2 du virus de la grippe A (immunologie)</term>
<term>Sous-type H9N2 du virus de la grippe A (isolement et purification)</term>
<term>Sujet âgé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Grippe chez les oiseaux</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H5N1 du virus de la grippe A</term>
<term>Sous-type H7N7 du virus de la grippe A</term>
<term>Sous-type H9N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H5N1 Subtype</term>
<term>Influenza A Virus, H7N7 Subtype</term>
<term>Influenza A Virus, H9N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term>
<term>Influenza A Virus, H7N7 Subtype</term>
<term>Influenza A Virus, H9N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H5N1 du virus de la grippe A</term>
<term>Sous-type H7N7 du virus de la grippe A</term>
<term>Sous-type H9N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Influenza in Birds</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe chez les oiseaux</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza in Birds</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Animals</term>
<term>Birds</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross Reactions</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Oiseaux</term>
<term>Réactions croisées</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Epidemics of influenza A vary greatly in size and age distribution of cases, and this variation is attributed to varying levels of pre-existing immunity. Recent studies have shown that antibody-mediated immune responses are more cross-reactive than previously believed, and shape patterns of humoral immunity to influenza A viruses over long periods. Here we quantify antibody responses to the hemagglutinin subunit 1 (HA1) across a range of subtypes using protein microarray analysis of cross-sectional serological surveys carried out in the Netherlands before and after the A/2009 (H1N1) pandemic. We find significant associations of responses, both within and between subtypes. Interestingly, substantial overall reactivity is observed to HA1 of avian H7N7 and H9N2 viruses. Seroprevalence of H7N7 correlates with antibody titers to A/1968 (H3N2), and is highest in persons born between 1954 and 1969. Seroprevalence of H9N2 is high across all ages, and correlates strongly with A/1957 (H2N2). This correlation is most pronounced in A/2009 (H1N1) infected persons born after 1968 who have never encountered A/1957 (H2N2)-like viruses. We conclude that heterosubtypic antibody cross-reactivity, both between human subtypes and between human and nonhuman subtypes, is common in the human population.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28715468</PMID>
<DateCompleted><Year>2017</Year>
<Month>09</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>12</Volume>
<Issue>7</Issue>
<PubDate><Year>2017</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).</ArticleTitle>
<Pagination><MedlinePgn>e0181093</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0181093</ELocationID>
<Abstract><AbstractText>Epidemics of influenza A vary greatly in size and age distribution of cases, and this variation is attributed to varying levels of pre-existing immunity. Recent studies have shown that antibody-mediated immune responses are more cross-reactive than previously believed, and shape patterns of humoral immunity to influenza A viruses over long periods. Here we quantify antibody responses to the hemagglutinin subunit 1 (HA1) across a range of subtypes using protein microarray analysis of cross-sectional serological surveys carried out in the Netherlands before and after the A/2009 (H1N1) pandemic. We find significant associations of responses, both within and between subtypes. Interestingly, substantial overall reactivity is observed to HA1 of avian H7N7 and H9N2 viruses. Seroprevalence of H7N7 correlates with antibody titers to A/1968 (H3N2), and is highest in persons born between 1954 and 1969. Seroprevalence of H9N2 is high across all ages, and correlates strongly with A/1957 (H2N2). This correlation is most pronounced in A/2009 (H1N1) infected persons born after 1968 who have never encountered A/1957 (H2N2)-like viruses. We conclude that heterosubtypic antibody cross-reactivity, both between human subtypes and between human and nonhuman subtypes, is common in the human population.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Te Beest</LastName>
<ForeName>Dennis E</ForeName>
<Initials>DE</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Bruin</LastName>
<ForeName>Erwin</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Imholz</LastName>
<ForeName>Sandra</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Koopmans</LastName>
<ForeName>Marion</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van Boven</LastName>
<ForeName>Michiel</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-0841-2400</Identifier>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>07</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001717" MajorTopicYN="N">Birds</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053124" MajorTopicYN="N">Influenza A Virus, H5N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053126" MajorTopicYN="N">Influenza A Virus, H7N7 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053127" MajorTopicYN="N">Influenza A Virus, H9N2 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005585" MajorTopicYN="N">Influenza in Birds</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>12</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>06</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28715468</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0181093</ArticleId>
<ArticleId IdType="pii">PONE-D-16-49021</ArticleId>
<ArticleId IdType="pmc">PMC5513445</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Opin Virol. 2017 Feb;22:105-111</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28088686</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2013 Aug 14;5(198):198ra107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23946196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22615367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2014 Nov 21;346(6212):996-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25414313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2007 Nov 30;7:141</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18047685</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24335589</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2015;386:381-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25193634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18238-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22042838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2017 Apr;18(4):464-473</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28192418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Virol. 2013 Oct;3(5):521-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23978327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Jul;88(13):7130-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24719430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Apr;87(8):4728-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23408625</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17040-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23027945</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 Nov 11;354(6313):722-726</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27846599</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2011 Mar;18(3):469-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21209157</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(1):e54890</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23365683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Comput Biol. 2012;8(10):e1002741</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23133346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2013 Jun;98(3):476-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23583287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2015 Mar 2;125(3):1255-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25689254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2012;8(7):e1002802</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22829765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2011 Jan 15;173(2):127-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21081646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dev Biol (Basel). 2003;115:63-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15088777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2011 Dec 1;174(11):1307-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22025354</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2014 Apr 10;157(2):294-299</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24725400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2016 Dec;22(12 ):1456-1464</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27820605</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 2013 Apr;1283:13-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23405860</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Jun;87(12):6542-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23576508</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J R Soc Interface. 2015 Feb 6;12(103):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25540241</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2010 May 18;1(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Apr 10;324(5924):246-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19251591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2004 Jul 16;305(5682):371-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15218094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2013 May;85(5):899-909</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23508915</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Dec;88(23):13580-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25210195</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2011 Aug 30;2(5):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21878571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2014 Nov 18;9(11):e113021</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25405997</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2015;386:301-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25007847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 2013 Nov 1;178(9):1469-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24029683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2723-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25730851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):872-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23331969</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24927560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2015;386:323-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25037260</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2011 Jan 17;208(1):181-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21220454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2012 Aug;18(8):797-807</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22212116</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2013 Aug 15;208(4):554-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23687225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Elife. 2014;3:e01914</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24497547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Biol. 2015 Mar 03;13(3):e1002082</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25734701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2012 Sep;12(9):687-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22738893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):843-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21737702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><country name="Pays-Bas"><noRegion><name sortKey="Te Beest, Dennis E" sort="Te Beest, Dennis E" uniqKey="Te Beest D" first="Dennis E" last="Te Beest">Dennis E. Te Beest</name>
</noRegion>
<name sortKey="De Bruin, Erwin" sort="De Bruin, Erwin" uniqKey="De Bruin E" first="Erwin" last="De Bruin">Erwin De Bruin</name>
<name sortKey="Imholz, Sandra" sort="Imholz, Sandra" uniqKey="Imholz S" first="Sandra" last="Imholz">Sandra Imholz</name>
<name sortKey="Koopmans, Marion" sort="Koopmans, Marion" uniqKey="Koopmans M" first="Marion" last="Koopmans">Marion Koopmans</name>
<name sortKey="Van Boven, Michiel" sort="Van Boven, Michiel" uniqKey="Van Boven M" first="Michiel" last="Van Boven">Michiel Van Boven</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000033 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000033 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28715468
   |texte=   Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28715468" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki